Reliv' International (RELV) Stock Price, News & Analysis

Company Overview

Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.

Key Stats

• Today's Range: $2.00 to $2.00
• 50-Day Range: $2.00 to $2.25
• 52-Week Range: $1.70 to $3.18
• Volume: N/A
• Average Volume: 657 shs
• Market Capitalization: $3.49 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RELV Stock Analysis - Frequently Asked Questions

How have RELV shares performed this year?

Reliv' International's stock was trading at $2.1544 at the beginning of 2026. Since then, RELV stock has decreased by 7.2% and is now trading at $2.00.

How were Reliv' International's earnings last quarter?

Reliv' International, Inc. (OTCMKTS:RELV) announced its earnings results on Friday, May, 15th. The company reported $0.38 EPS for the quarter. The firm earned $10.28 million during the quarter. Reliv' International had a negative net margin of 0.61% and a negative trailing twelve-month return on equity of 1.89%.

How do I buy shares of Reliv' International?

Shares of RELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Reliv' International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Reliv' International investors own include Enterprise Products Partners (EPD), Aquestive Therapeutics (AQST), Ocean Power Technologies (OPTT), Rigel Pharmaceuticals (RIGL), Sonoma Pharmaceuticals (SNOA) and

Company Calendar

• Last Earnings: 5/15/2020
• Today: 5/05/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RELV
• CIK: 768710
• Web: www.reliv.com
• Phone: 636-537-9715
• Fax: N/A
• Employees: 91
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$440 thousand
• Net Margins: -0.61%
• Pretax Margin: N/A
• Return on Equity: -1.89%
• Return on Assets: -1.31%

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 1.70
• Quick Ratio: 1.04

Sales & Book Value

• Annual Sales: $35.06 million
• Price / Sales: 0.10
• Cash Flow: $0.04 per share
• Price / Cash Flow: 44.53
• Book Value: $6.36 per share
• Price / Book: 0.31

Miscellaneous

• Outstanding Shares: 1,746,000
• Free Float: N/A
• Market Cap: $3.49 million
• Optionable: Not Optionable
• Beta: -0.04